Skip to main content
. 2022 Jan 10;2022:2066133. doi: 10.1155/2022/2066133

Table 4.

Risk of suicide among individuals with a second malignant neoplasm (SMN) diagnosis, by characteristics of the first malignancy, compared with individuals with a first malignant neoplasm (FMN) diagnosis.

No. of suicide cases/no. of accumulated person-years × 10,000 (incidence rate/10,000 person-years) Hazard ratioa (95% confidence interval) P difference
SMN FMN
By FMN tumor size, cm 0.57
 <1.5 62/260,141.08 (2.38) 758/5,869,076.38 (1.29) 1.55 (0.77–3.12)
 ≥1.5 285/839,718.17 (3.39) 3,640/16,163,041.38 (2.25) 1.26 (1.06–1.50)
By FMN grade 0.54
 Well differentiated 118/318,247.38 (3.71) 1,000/5,384,767.58 (1.86) 1.39 (0.82–2.36)
 Moderately differentiated 334/817,983.33 (4.08) 3,179/14,044,744.63 (2.26) 1.65 (1.37–1.99)
 Poorly differentiated/undifferentiated 212/466,502.54 (4.54) 2,696/8,978,857.25 (3.00) 1.86 (1.47–2.37)
By FMN chemotherapy/radiotherapy 0.013
 No/unknown 590/1,525,397.25 (3.87) 6,701/25,942,336.79 (2.58) 1.28 (1.16–1.41)
 Yes 347/875,755.67 (3.96) 4,229/18,163,622.13 (2.33) 1.64 (1.39–1.95)
By FMN surgery 0.045
 No/unknown 272/512,397.08 (5.31) 4,654/10,600,572.79 (4.39) 1.18 (0.99–1.40)
 Yes 665/1,888,755.83 (3.52) 6,276/33,505,386.13 (1.87) 1.45 (1.31–1.61)

aCox model was used to estimate hazard ratios (HRs), adjusted for birth year, sex, calendar year, race, cohabitation status, insurance, state, tumor size, grade, chemotherapy/radiotherapy, and surgery.